ArticleFrontiers in pediatrics2026
Case Report: Hidden B-cell dysregulation in MIRAGE syndrome.
Article in Frontiers in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aim: To characterize the immune and molecular abnormalities underlying MIRAGE syndrome by profiling peripheral blood transcriptomes and assessing immune cell composition and function in affected patients. Methods: We performed RNA sequencing on peripheral whole-blood samples collected from identical twins diagnosed with MIRAGE syndrome and their healthy parents. Bulk RNA-seq data were subsequently deconvoluted to assess the composition, state, and functional characteristics of immune cell populations. Results: Differentially expressed genes between patients and healthy parents were significantly enriched in the PI3K-Akt signaling pathway, B-cell receptor signaling pathway, and primary immunodeficiency-related pathways. Patients exhibited reduced proportions of memory and naïve B cells, accompanied by increased proportions of CD8 T cells and M2 macrophages. We further identified the top 10 hub genes, which showed moderate to strong correlations with B-cell differentiation, proliferation, and activation. Conclusion: Immune cell dysregulation is evident in patients with MIRAGE syndrome, with B-cell abnormalities representing a prominent immunological feature.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.